Nawan Butt, Portfolio Manager of The Medical Cannabis and Wellness UCITS ETF<\/strong><\/strong><\/strong><\/p>\n
\nIt has focused on the medical side of Cannabis with pharmaceutical companies such as GW Pharma at the core of its portfolio \u2013 it accounts for around 14% of the fund\u2019s holdings.<\/p>\n
Nawan Butt, Portfolio Manager of The Medical Cannabis and Wellness UCITS ETF<\/strong>, said: \u201cGW Pharmaceuticals PLC is a UK based company that made history by getting the first FDA approved drug derived from Cannabis. Their drug, Epidiolex has changed the lives of many living with epilepsy, and they are building out a platform looking at other areas.<\/p>\nWhen they started most global pharma companies were hesitant to do work with this plant ignoring centuries of evidence there were some health benefits. As times are changing and attitudes adjusting, more and more companies are getting involved with the sector. <\/strong><\/p>\nToday could be a notable turning point as a more traditional pharma company, JAZZ pharma, has agreed to purchase GW Pharma for over $7B. We don\u2019t think this is the last deal we will see in the sector.<\/p>\n
\u201cOne of the sectors that benefited the most from the US results was Cannabis. The sector is still in the early phase of its growth to becoming a more mainstream Consumer and Healthcare category and with the Democrats in power we expect the move towards legalization in the US to speed up. With is reality becoming more widely appreciated we have seen many of the US recreational focused cannabis names do extremely well over the past month. But now the focus of the sector could switch to the medical side.<\/strong><\/p>\nToday\u2019s events should draw attention to other companies doing work in this sector and the opportunities they are exploring.\u201d<\/p>\n
Source: ETFWorld.co.uk<\/p>\n","protected":false},"excerpt":{"rendered":"
HANetf : The Medical Cannabis and Wellness UCITS ETF is Europe\u2019s first ETF focused on cannabis. The fund trades in London under CBDX and in Germany as CBSX and is passported for sale across Europe.<\/p>\n","protected":false},"author":4,"featured_media":21916,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"telegram_tosend":false,"telegram_tosend_message":"","telegram_tosend_target":0,"footnotes":"","_wpscp_schedule_draft_date":"","_wpscp_schedule_republish_date":"","_wpscppro_advance_schedule":false,"_wpscppro_advance_schedule_date":"","_wpscppro_dont_share_socialmedia":false,"_wpscppro_custom_social_share_image":0,"_facebook_share_type":"","_twitter_share_type":"","_linkedin_share_type":"","_pinterest_share_type":"","_linkedin_share_type_page":"","_instagram_share_type":"","_medium_share_type":"","_threads_share_type":"","_google_business_share_type":"","_selected_social_profile":[],"_wpsp_enable_custom_social_template":false,"_wpsp_social_scheduling":{"enabled":false,"datetime":null,"platforms":[],"status":"template_only","dateOption":"today","timeOption":"now","customDays":"","customHours":"","customDate":"","customTime":"","schedulingType":"absolute"},"_wpsp_active_default_template":true},"categories":[12],"tags":[204],"class_list":["post-22340","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-etf-analyse","tag-hanetf"],"blocksy_meta":{"styles_descriptor":{"styles":{"desktop":"","tablet":"","mobile":""},"google_fonts":[],"version":6}},"_links":{"self":[{"href":"https:\/\/www.etfworld.com\/nl\/wp-json\/wp\/v2\/posts\/22340","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.etfworld.com\/nl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.etfworld.com\/nl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.etfworld.com\/nl\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.etfworld.com\/nl\/wp-json\/wp\/v2\/comments?post=22340"}],"version-history":[{"count":2,"href":"https:\/\/www.etfworld.com\/nl\/wp-json\/wp\/v2\/posts\/22340\/revisions"}],"predecessor-version":[{"id":22342,"href":"https:\/\/www.etfworld.com\/nl\/wp-json\/wp\/v2\/posts\/22340\/revisions\/22342"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.etfworld.com\/nl\/wp-json\/wp\/v2\/media\/21916"}],"wp:attachment":[{"href":"https:\/\/www.etfworld.com\/nl\/wp-json\/wp\/v2\/media?parent=22340"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.etfworld.com\/nl\/wp-json\/wp\/v2\/categories?post=22340"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.etfworld.com\/nl\/wp-json\/wp\/v2\/tags?post=22340"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}